{"gene":"PSMC3","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":1996,"finding":"The 26S proteasome 19S regulatory complex contains multiple ATPase subunits (including PSMC3/Rpt5) that are required for binding and unfolding ubiquitinated protein substrates prior to degradation by the 20S core particle; the ATPases form a ring that drives substrate translocation through the gated channel.","method":"Biochemical purification, enzymatic assays, subunit characterization","journal":"Annual review of biochemistry","confidence":"High","confidence_rationale":"Tier 1-2 — foundational biochemical reconstitution and purification work, widely replicated across labs","pmids":["8811196"],"is_preprint":false},{"year":1997,"finding":"Rat testis TBP-1 (rtTBP-1, the PSMC3 ortholog) encodes a 49 kDa protein with a leucine zipper domain and conserved ATPase/helicase motifs. By immunofluorescence and immunogold electron microscopy, rtTBP-1 colocalizes with α-tubulin-decorated manchettes of elongating spermatids and is also detected in paraaxonemal mitochondria and outer dense fibers of the developing spermatid tail.","method":"Immunofluorescence, immunogold electron microscopy, chromatofocusing fractionation, in situ hybridization","journal":"Molecular reproduction and development","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization by multiple imaging methods in a single study","pmids":["9266764"],"is_preprint":false},{"year":1997,"finding":"PSMC3 (TBP-1/Rpt5) was chromosomally mapped to human chromosome 11p12-p13, and a processed pseudogene locus was identified on chromosome 9p.","method":"Fluorescence in situ hybridization (FISH), radiation hybrid mapping","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 — direct cytogenetic mapping","pmids":["9048938"],"is_preprint":false},{"year":1997,"finding":"TBPIP (TBP-1-interacting protein) was cloned from mouse and shown to interact with mouse TBP-1 (PSMC3 ortholog) in vivo; TBPIP co-localizes with TBP-1 and synergistically enhances TBP-1's inhibitory action on HIV-1 Tat-mediated transactivation in vitro.","method":"Yeast two-hybrid, co-localization, in vitro transactivation assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — yeast two-hybrid plus functional assay in single study","pmids":["9345291"],"is_preprint":false},{"year":1998,"finding":"Mouse TBP-1 (PSMC3) is primarily localized to the nuclei of spermatogonia and spermatocytes in the testis, as demonstrated by immunohistochemistry; expression is also confirmed in CD4+ lymphocytes by RT-PCR, indicating heterogeneous tissue distribution.","method":"Immunohistochemistry, in situ hybridization, RT-PCR","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct localization experiments with multiple methods","pmids":["9714759"],"is_preprint":false},{"year":1999,"finding":"PSMC3 (S6'/TBP-1) is a component of an activator complex (modulator) that, together with S10b (SUG2), stimulates 20S proteasome activity in an ATP- and concentration-dependent manner. This activator complex was isolated from bovine red cells and human tissues (brain, placenta, HEK cells) and also activates 26S proteasomes in a cross-species manner.","method":"Biochemical purification, 20S proteasome activity assay, cross-species activation experiments","journal":"Molecular biology reports","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro functional assay with purified components, replicated across tissues and species","pmids":["10363644"],"is_preprint":false},{"year":2000,"finding":"Mouse Psmc3 gene consists of 12 coding exons with structural similarity to Psmc4; Psmc3 maps to mouse chromosome 2. Gene-targeted Psmc3-deficient mice die before implantation with defective blastocyst development, demonstrating that PSMC3 is essential for early embryogenesis and that Psmc3 and Psmc4 have non-compensatory functions in vivo.","method":"Gene targeting (knockout mice), genomic sequencing, embryo analysis","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 2 — clean knockout with defined lethal phenotype, rigorous genetic study","pmids":["10945464"],"is_preprint":false},{"year":2007,"finding":"TBP-1 (PSMC3) stabilizes the p14ARF tumor suppressor by protecting it from 20S proteasome-mediated degradation. This stabilization requires an intact N-terminal 39 amino acids of ARF and occurs independently of N-terminal ubiquitination. In vitro, p14ARF can be degraded by the 20S proteasome without ubiquitination, and this degradation is counteracted by TBP-1.","method":"In vitro 20S proteasome degradation assay, co-immunoprecipitation, western blotting, deletion mutagenesis","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution assay combined with mutagenesis and co-IP in single study","pmids":["17334400"],"is_preprint":false},{"year":2009,"finding":"During rat spermatid development, PSMC3 (a component of the 19S regulatory cap of the 26S proteasome) and the ubiquitin E3 ligase Rnf19a are initially found in Golgi-derived proacrosomal vesicles, then localize along the cytosolic side of acrosomal membranes and the acroplaxome, and subsequently accumulate at the acroplaxome marginal ring-manchette perinuclear ring region and the developing head-tail coupling apparatus, implicating the ubiquitin-proteasome system in acrosome biogenesis and spermatid head shaping.","method":"Immunofluorescence, immunogold electron microscopy, cDNA cloning, co-localization studies","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct localization by multiple imaging methods with functional context","pmids":["19517565"],"is_preprint":false},{"year":2009,"finding":"The 19S ATPase S6a (TBP-1/PSMC3) is required for cytokine-inducible CIITA transcription: knockdown of S6a reduces recruitment of transcription factors to the CIITA interferon-γ-inducible promoter IV (pIV), decreases histone H3K18 and H4K8 acetylation at that promoter, and impairs CIITA mRNA expression. S6b (another 19S ATPase) binds CIITApIV in an S6a-dependent manner, implicating the 19S ATPase hexamer in transcriptional initiation machinery assembly.","method":"siRNA knockdown, chromatin immunoprecipitation (ChIP), RT-PCR, reporter assays","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and functional knockdown with multiple readouts in single study","pmids":["19853614"],"is_preprint":false},{"year":2009,"finding":"TBP-1 (PSMC3) directly binds TBPIP through its amino-terminal leucine zipper domain. AR (androgen receptor) is physically associated with TBP-1 and TBPIP both in vitro and in LNCaP cells. TBP-1 augments AR-mediated transcription additively with TBPIP, and the ATPase domain as well as the leucine zipper domain of TBP-1 are required for transcriptional enhancement. TBP-1 is transiently recruited to the proximal androgen response element of the PSA gene promoter in a ligand-dependent manner.","method":"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, chromatin immunoprecipitation (ChIP), reporter assay, mutagenesis","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including in vitro binding, co-IP, ChIP, and domain mutagenesis in single study","pmids":["19325002"],"is_preprint":false},{"year":2011,"finding":"The C-terminal tail of yeast Rpt5 (PSMC3 ortholog) provides two distinct functions: (1) facilitating the interaction with the proteasome core particle (CP), and (2) enabling binding to the assembly chaperone Nas2/p27. Deletion of the last C-terminal amino acid disrupts CP interaction but not Nas2 binding; deletion of the last three amino acids disrupts both. Proteasomes from rpt5-Δ3 strains are strongly enriched in Ecm29, which inhibits proteasome activity (reduced suc-LLVY-AMC hydrolysis). Deletion of ECM29 rescues the phenotypes of rpt5-Δ3 and nas2Δ in an hsm3Δ background, demonstrating that Ecm29 acts as a negative regulator of faulty proteasomes.","method":"Site-directed mutagenesis, proteasome purification, enzymatic activity assay, genetic epistasis, yeast genetics","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — mutagenesis combined with biochemical purification, enzymatic assay, and genetic epistasis in single study","pmids":["21878651"],"is_preprint":false},{"year":2011,"finding":"Stable knockdown of TBP-1 (PSMC3) in human immortalized fibroblasts increases cell proliferation, migration, and resistance to serum deprivation-induced apoptosis. TBP-1 silencing activates Akt/PKB kinase, and TBP-1 is itself a downstream target of Akt/PKB. MDM2, a known Akt target, plays a major role in this regulation, suggesting a negative feedback loop where Akt/PKB modulates TBP-1 levels in proliferating cells.","method":"Stable shRNA knockdown, proliferation assays, migration assays, apoptosis assay, western blotting, kinase pathway analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2-3 — loss-of-function with multiple phenotypic readouts and pathway placement, single lab","pmids":["21991300"],"is_preprint":false},{"year":2013,"finding":"The 26S proteasome AAA-ATPase subunit RPT5 (PSMC3 ortholog) acts as a molecular chaperone that prevents aggregation of denatured ricin A chain (RTA) and stimulates recovery of RTA catalytic activity in vitro. Denatured RTA and casein compete for the same binding site on the regulatory particle of the 26S proteasome, but their fates differ: casein is degraded while RTA is not. In vivo, ATPase activity of yeast Rpt5p is required for maximal RTA toxicity after ER dislocation, implicating RPT5 in substrate triage between folding and degradation pathways.","method":"In vitro aggregation assay, proteasome binding competition, catalytic activity measurement, yeast genetic analysis","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution of chaperone activity plus in vivo genetic validation","pmids":["23617410"],"is_preprint":false},{"year":2014,"finding":"The N-terminal domain of the assembly chaperone p27 (residues 1-128, mouse) was crystallized alone (1.7 Å resolution, space group P212121) and in complex with the C-terminal ATPase domain of Rpt5/PSMC3 (residues 173-442; 4 Å resolution, space group P222), revealing that the p27 N-terminus directly contacts the Rpt5 ATPase domain and providing structural evidence for their interaction in proteasome assembly.","method":"X-ray crystallography, protein purification, co-crystallization","journal":"Acta crystallographica. Section F, Structural biology communications","confidence":"Medium","confidence_rationale":"Tier 1 — crystal structure obtained but at low resolution for complex (4 Å); preliminary structural data","pmids":["24817721"],"is_preprint":false},{"year":2020,"finding":"A deep intronic homozygous variant in PSMC3 leads to transcription of a cryptic exon and impaired protein homeostasis in patient fibroblasts, characterized by accumulation of ubiquitinated proteins (proteotoxic stress). The TCF11/Nrf1 transcriptional pathway for proteasome recovery is constitutively activated in patient cells, but upon chemical proteasome inhibition, this compensatory pathway is impaired. Zebrafish knockout of PSMC3 reproduces the human phenotype with inner ear development anomalies and cataracts, demonstrating a critical role for PSMC3/Rpt5 in inner ear, lens, and CNS development.","method":"Whole-genome sequencing, patient fibroblast studies, ubiquitination assays, proteasome activity assays, zebrafish knockout modeling, transcriptional pathway analysis","journal":"EMBO molecular medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (biochemical, cell biology, in vivo modeling) with defined molecular and phenotypic readouts","pmids":["32500975"],"is_preprint":false},{"year":2022,"finding":"PSMC3 is a novel binding partner of AGO2 (Argonaute 2), interacting via the N-terminal coiled-coil motif of PSMC3 in an RNA-independent manner. PSMC3 depletion decreases AGO2 protein amount by promoting its ubiquitination and subsequent 26S proteasome-mediated degradation, whereas PSMC3 overexpression stabilizes AGO2 post-translationally. Mechanistically, PSMC3 facilitates the interaction of AGO2 with the deubiquitylase USP14, promoting USP14-mediated deubiquitination of AGO2, thereby stabilizing AGO2 and maintaining effective RNAi activity.","method":"Yeast two-hybrid screen, co-immunoprecipitation, immunofluorescence, truncation mutagenesis, cycloheximide chase, ubiquitination assay, EGFP-RNAi reporter assay, western blotting","journal":"Cellular & molecular biology letters","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including co-IP, mutagenesis, ubiquitination assay, and functional RNAi readout in single study","pmids":["36528617"],"is_preprint":false},{"year":2022,"finding":"VCPIP1 (a deubiquitinating enzyme) recruits PSMC3 to form a ternary complex with the hepatitis B virus X protein (HBx), stabilizing HBx through a ubiquitin-independent pathway. In vitro, purified His-tagged PSMC3 rescues HBx from 20S proteasome-mediated degradation. VCPIP1 synergizes this stabilization in vivo. The ternary VCPIP1-HBx-PSMC3 complex enhances HBx transcriptional transactivation (NF-κB, AP-1, SP-1) and affects cccDNA transcription.","method":"Yeast two-hybrid, co-immunoprecipitation, in vitro degradation assay with purified proteins, reporter assay, western blotting","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution with purified PSMC3 protein combined with co-IP and functional assays","pmids":["35695579"],"is_preprint":false},{"year":2022,"finding":"Rpt5 (PSMC3) in glial cells reversibly associates with cold-stable microtubules upon cold stress, while other 19S and 20S subunits do not show this redistribution. This relocalization coincides with 26S proteasome partial disassembly and reduced 20S proteolytic activity. Both MAP6 expression and post-translational acetylation of α-tubulin modulate the Rpt5-microtubule association.","method":"Immunofluorescence, subcellular fractionation, 20S proteasome activity assay, western blotting, glial cell culture cold stress experiments","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2-3 — direct localization with functional consequence (proteasome disassembly), single lab","pmids":["35114005"],"is_preprint":false},{"year":2023,"finding":"Fifteen de novo missense variants in PSMC3 cause an autosomal dominant neurodevelopmental delay syndrome. Expression of PSMC3 variants in mouse neuronal cultures leads to altered dendrite development. Deletion of the PSMC3 Drosophila ortholog Rpt5 impairs reversal learning. Structural modeling and proteomic/transcriptomic analyses of patient T cells indicate that PSMC3 variants disrupt substrate translocation, induce proteotoxic stress, and dysregulate type I interferon (IFN) signaling through activation of the intracellular stress sensor PKR (protein kinase R). Inhibition of PKR blocks the type I IFN response in patient-derived T cells.","method":"Patient genetics, structural modeling, mouse neuronal culture with morphological readout, Drosophila behavioral assay, proteomics, transcriptomics, PKR inhibitor treatment","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods across human cells, mouse neurons, and Drosophila model with defined pathway placement (PKR-IFN axis)","pmids":["37256937"],"is_preprint":false},{"year":2024,"finding":"Procyanidin B1 mediates interaction between PSMC3 and NRF2 to promote ubiquitin-dependent proteasomal degradation of NRF2 in glioblastoma cells, inducing ferroptosis. PSMC3-NRF2 interaction was demonstrated by immunoprecipitation and mass spectrometry; the mechanism involves enhanced H₂O₂ accumulation through NRF2 downregulation. Procyanidin B1 binding to NRF2 was confirmed by surface plasmon resonance and protein-small molecule docking.","method":"Protein-small molecule docking, surface plasmon resonance, z-stack laser confocal imaging, immunoprecipitation, mass spectrometry, western blotting, in vivo orthotopic GBM model","journal":"Phytotherapy research","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP and MS combined with in vivo model, but mechanistic link of PSMC3 to NRF2 ubiquitination needs further validation","pmids":["39293861"],"is_preprint":false},{"year":2024,"finding":"Synthetic peptides and peptidomimetics derived from the C-terminus of the Rpt5 (PSMC3) subunit of the 19S regulatory particle efficiently stimulate human 20S proteasome activity in vitro. Cell-penetrating TAT-conjugated versions stimulate proteasome activity in HEK293T cells (measured with cell-permeable substrate TAS3) and enhance degradation of aggregation-prone α-synuclein and Tau-441.","method":"Peptide synthesis, in vitro 20S proteasome activity assay, cell-based proteasome activity assay, western blotting for substrate degradation","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1-2 — in vitro biochemical assay with defined substrate degradation, extended to cell-based validation","pmids":["38731881"],"is_preprint":false}],"current_model":"PSMC3 (Rpt5) is an essential AAA-ATPase subunit of the 19S regulatory particle of the 26S proteasome whose C-terminal tail mediates interactions with both the 20S core particle and the assembly chaperone Nas2/p27; it drives substrate unfolding and translocation for ubiquitin-dependent proteolysis, acts as a molecular chaperone to prevent substrate aggregation, stimulates 20S proteasome activity in a defined activator complex, participates in transcriptional regulation (CIITA, androgen receptor, p14ARF stabilization) through its leucine zipper and ATPase domains, stabilizes AGO2 by facilitating USP14-mediated deubiquitination to maintain RNAi, and its dysfunction causes proteotoxic stress with constitutive TCF11/Nrf1 pathway activation and type I IFN signaling through PKR, resulting in neurodevelopmental and sensory syndromes; it is essential for early embryogenesis, spermatid development, and inner ear/lens development."},"narrative":{"teleology":[{"year":1996,"claim":"Establishing that PSMC3/Rpt5 is a core ATPase subunit of the 19S regulatory particle resolved the enzymatic basis of substrate recognition and translocation in ubiquitin-dependent proteolysis.","evidence":"Biochemical purification and enzymatic characterization of the 26S proteasome subunits","pmids":["8811196"],"confidence":"High","gaps":["Substrate specificity determinants of individual ATPase subunits were not resolved","Structural arrangement of the ATPase ring was unknown"]},{"year":1997,"claim":"Localization of PSMC3 to spermatid manchettes and identification of its leucine zipper domain suggested non-proteasomal roles in germ cell differentiation, expanding PSMC3 function beyond bulk proteolysis.","evidence":"Immunofluorescence and immunogold electron microscopy in rat spermatids; domain analysis","pmids":["9266764","9345291"],"confidence":"Medium","gaps":["Functional consequence of manchette localization was not tested","TBPIP interaction validated only by yeast two-hybrid in single study"]},{"year":1999,"claim":"Demonstration that PSMC3 together with SUG2 forms an activator complex stimulating 20S proteasome activity in an ATP-dependent manner established that individual 19S ATPases can function outside the intact 26S holoenzyme.","evidence":"Purification from bovine red cells and human tissues with in vitro 20S proteasome activity assay","pmids":["10363644"],"confidence":"Medium","gaps":["Physiological context for a free PSMC3-SUG2 activator complex was not defined","Stoichiometry and regulation of the activator complex were not characterized"]},{"year":2000,"claim":"Psmc3 knockout in mice demonstrated pre-implantation lethality with defective blastocyst development, proving that PSMC3 is non-redundant with Psmc4 and essential for early embryogenesis.","evidence":"Gene-targeted knockout mice with embryo analysis","pmids":["10945464"],"confidence":"High","gaps":["Whether lethality arises from global proteasome failure versus a specific PSMC3 function was unresolved","Cell-type-specific requirements were not addressed"]},{"year":2007,"claim":"Showing that PSMC3 protects p14ARF from ubiquitin-independent 20S proteasome degradation revealed a substrate-stabilization function distinct from its role in 26S-dependent proteolysis.","evidence":"In vitro 20S proteasome degradation assay with purified components, co-IP, and deletion mutagenesis","pmids":["17334400"],"confidence":"High","gaps":["Whether p14ARF stabilization occurs through direct binding or steric exclusion from the 20S gate was not resolved","In vivo relevance for tumor suppression was not demonstrated"]},{"year":2009,"claim":"Two contemporaneous studies established transcription-regulatory roles for PSMC3: it is required for CIITA promoter activation through histone acetylation and transcription factor recruitment, and it enhances androgen receptor transactivation via its leucine zipper and ATPase domains.","evidence":"siRNA knockdown with ChIP and RT-PCR for CIITA; GST pulldown, co-IP, ChIP, and reporter assays with domain mutagenesis for AR","pmids":["19853614","19325002"],"confidence":"High","gaps":["Whether transcriptional roles require assembled 19S particles or free PSMC3 was not distinguished","Genome-wide scope of PSMC3 transcriptional targets was unknown"]},{"year":2011,"claim":"Dissection of the Rpt5 C-terminal tail revealed separable functions for 20S core particle docking and Nas2 chaperone binding, establishing how assembly intermediates are guided to the mature holoenzyme.","evidence":"C-terminal truncation mutagenesis in yeast combined with proteasome purification, enzymatic assays, and genetic epistasis with ECM29","pmids":["21878651"],"confidence":"High","gaps":["Structural basis of the C-tail–CP interface at atomic resolution was not obtained","How Ecm29 senses faulty proteasomes mechanistically was unclear"]},{"year":2013,"claim":"Reconstitution of chaperone activity demonstrated that PSMC3/Rpt5 prevents substrate aggregation and promotes refolding, establishing a triage function between folding and degradation at the proteasome.","evidence":"In vitro aggregation assay with denatured ricin A chain, competition binding, and yeast ATPase-mutant genetic validation","pmids":["23617410"],"confidence":"High","gaps":["Range of endogenous substrates subject to PSMC3-mediated triage was uncharacterized","Structural basis of chaperone versus degradation commitment was unknown"]},{"year":2020,"claim":"Identification of a pathogenic deep intronic PSMC3 variant causing proteotoxic stress, constitutive TCF11/Nrf1 activation, and inner ear/lens developmental anomalies in humans and zebrafish linked PSMC3 dysfunction to a human sensory-developmental syndrome.","evidence":"Whole-genome sequencing of patients, fibroblast proteostasis assays, and zebrafish PSMC3 knockout phenotyping","pmids":["32500975"],"confidence":"High","gaps":["Whether TCF11/Nrf1 pathway exhaustion is the proximal cause of tissue-specific defects was not tested","Genotype-phenotype correlation across different variant types was limited"]},{"year":2022,"claim":"Discovery that PSMC3 stabilizes AGO2 by facilitating USP14-mediated deubiquitination revealed a proteasome-independent post-translational mechanism through which PSMC3 sustains RNA interference.","evidence":"Yeast two-hybrid, co-IP, truncation mutagenesis, cycloheximide chase, ubiquitination assay, and EGFP-RNAi reporter","pmids":["36528617"],"confidence":"High","gaps":["Whether PSMC3-AGO2 interaction occurs as free protein or within 19S context was not resolved","Impact on specific miRNA pathways or global small RNA populations was not assessed"]},{"year":2023,"claim":"Characterization of 15 de novo PSMC3 missense variants established an autosomal dominant neurodevelopmental syndrome and revealed that proteotoxic stress activates PKR-driven type I interferon signaling, identifying a druggable inflammatory axis downstream of proteasome dysfunction.","evidence":"Patient genetics, mouse neuronal morphology, Drosophila behavioral assay, proteomics/transcriptomics, PKR inhibitor treatment in patient T cells","pmids":["37256937"],"confidence":"High","gaps":["Whether PKR activation is specific to PSMC3 variants or generalizable to other proteasome subunit mutations was untested","Long-term efficacy of PKR inhibition in vivo was not assessed"]},{"year":null,"claim":"Key unresolved questions include: how PSMC3 partitions between proteasomal, transcriptional, and chaperone roles in different cell types; the structural basis for substrate triage at the intact 26S holoenzyme; and whether therapeutic activation of the 20S proteasome via Rpt5-derived peptides can ameliorate neurodegenerative proteinopathies in vivo.","evidence":"","pmids":[],"confidence":"Low","gaps":["No in vivo pharmacological validation of Rpt5 C-terminal peptides in neurodegeneration models","Cell-type-specific partitioning of PSMC3 functions is unexplored","High-resolution cryo-EM of PSMC3 in chaperone versus degradation states is lacking"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,5,11,13]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,7,16,17]},{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[13]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[9,10]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,16,21]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,9,10]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,5,16]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[1,18]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,5,7,11,13,16,17,21]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[9,10]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[19]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[16]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[6,15]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[15,19]}],"complexes":["26S proteasome 19S regulatory particle","PSMC3-SUG2 proteasome activator complex"],"partners":["PSMC4","PSMD5","AGO2","USP14","VCPIP1","AR","TBPIP","NAS2"],"other_free_text":[]},"mechanistic_narrative":"PSMC3 (Rpt5/TBP-1) is an essential AAA-ATPase subunit of the 19S regulatory particle of the 26S proteasome that drives ATP-dependent unfolding and translocation of ubiquitinated substrates into the 20S core for degradation, with its C-terminal tail mediating both 20S core particle docking and assembly chaperone Nas2/p27 binding [PMID:8811196, PMID:21878651, PMID:24817721]. Beyond canonical proteolysis, PSMC3 functions as a molecular chaperone that prevents substrate aggregation, stabilizes p14ARF against ubiquitin-independent 20S degradation, and maintains AGO2 protein levels by facilitating USP14-mediated deubiquitination to sustain RNAi [PMID:23617410, PMID:17334400, PMID:36528617]. PSMC3 also participates in transcriptional regulation, being recruited to promoters of CIITA and androgen receptor target genes through its leucine zipper and ATPase domains [PMID:19853614, PMID:19325002]. De novo missense variants in PSMC3 cause an autosomal dominant neurodevelopmental syndrome characterized by proteotoxic stress and dysregulated type I interferon signaling via PKR, while biallelic loss-of-function variants produce inner ear and lens developmental anomalies [PMID:37256937, PMID:32500975]."},"prefetch_data":{"uniprot":{"accession":"P17980","full_name":"26S proteasome regulatory subunit 6A","aliases":["26S proteasome AAA-ATPase subunit RPT5","Proteasome 26S subunit ATPase 3","Proteasome subunit P50","Tat-binding protein 1","TBP-1"],"length_aa":439,"mass_kda":49.2,"function":"Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC3 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/P17980/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/PSMC3","classification":"Common Essential","n_dependent_lines":1207,"n_total_lines":1208,"dependency_fraction":0.9991721854304636},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000165916","cell_line_id":"CID000104","localizations":[{"compartment":"cytoplasmic","grade":3},{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"PSMA1","stoichiometry":10.0},{"gene":"PSMA2","stoichiometry":10.0},{"gene":"PSMA3","stoichiometry":10.0},{"gene":"PSMA4","stoichiometry":10.0},{"gene":"PSMA5","stoichiometry":10.0},{"gene":"PSMA6","stoichiometry":10.0},{"gene":"PSMB1","stoichiometry":10.0},{"gene":"PSMB2","stoichiometry":10.0},{"gene":"PSMB3","stoichiometry":10.0},{"gene":"PSMB4","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/target/CID000104","total_profiled":1310},"omim":[{"mim_id":"621539","title":"EBSTEIN-BEZIEAU NEURODEVELOPMENTAL SYNDROME; EBNDS","url":"https://www.omim.org/entry/621539"},{"mim_id":"619354","title":"DEAFNESS, CATARACT, IMPAIRED INTELLECTUAL DEVELOPMENT, AND POLYNEUROPATHY; DCIDP","url":"https://www.omim.org/entry/619354"},{"mim_id":"614324","title":"OVARIAN DYSGENESIS 3; ODG3","url":"https://www.omim.org/entry/614324"},{"mim_id":"611176","title":"JNK/MAPK8-ASSOCIATED MEMBRANE PROTEIN; JKAMP","url":"https://www.omim.org/entry/611176"},{"mim_id":"608665","title":"PSMC3-INTERACTING PROTEIN; PSMC3IP","url":"https://www.omim.org/entry/608665"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"},{"location":"Nuclear bodies","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PSMC3"},"hgnc":{"alias_symbol":["TBP1","TBP-1","RPT5"],"prev_symbol":[]},"alphafold":{"accession":"P17980","domains":[{"cath_id":"2.40.50.140","chopping":"86-101_117-162","consensus_level":"high","plddt":81.879,"start":86,"end":162},{"cath_id":"3.40.50.300","chopping":"171-352","consensus_level":"high","plddt":82.9915,"start":171,"end":352},{"cath_id":"1.10.8.60","chopping":"358-432","consensus_level":"high","plddt":89.1784,"start":358,"end":432},{"cath_id":"1.20.5","chopping":"24-80","consensus_level":"high","plddt":83.0104,"start":24,"end":80}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P17980","model_url":"https://alphafold.ebi.ac.uk/files/AF-P17980-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P17980-F1-predicted_aligned_error_v6.png","plddt_mean":80.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PSMC3","jax_strain_url":"https://www.jax.org/strain/search?query=PSMC3"},"sequence":{"accession":"P17980","fasta_url":"https://rest.uniprot.org/uniprotkb/P17980.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P17980/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P17980"}},"corpus_meta":[{"pmid":"15779989","id":"PMC_15779989","title":"Specificity and biomineralization activities of Ti-binding peptide-1 (TBP-1).","date":"2005","source":"Langmuir : the ACS journal of surfaces and colloids","url":"https://pubmed.ncbi.nlm.nih.gov/15779989","citation_count":145,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8344530","id":"PMC_8344530","title":"Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2.","date":"1993","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8344530","citation_count":134,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19223514","id":"PMC_19223514","title":"The Arabidopsis proteasome RPT5 subunits are essential for gametophyte development and show accession-dependent redundancy.","date":"2009","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/19223514","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32500975","id":"PMC_32500975","title":"Proteasome subunit PSMC3 variants cause neurosensory syndrome combining deafness and cataract due to proteotoxic stress.","date":"2020","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32500975","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21878651","id":"PMC_21878651","title":"Loss of Rpt5 protein interactions with the core particle and Nas2 protein causes the formation of faulty proteasomes that are inhibited by Ecm29 protein.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21878651","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19517565","id":"PMC_19517565","title":"Rnf19a, a ubiquitin protein ligase, and Psmc3, a component of the 26S proteasome, tether to the acrosome membranes and the head-tail coupling apparatus during rat spermatid development.","date":"2009","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/19517565","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9266764","id":"PMC_9266764","title":"A protein associated with the manchette during rat spermiogenesis is encoded by a gene of the TBP-1-like subfamily with highly conserved ATPase and protease domains.","date":"1997","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/9266764","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10945464","id":"PMC_10945464","title":"Mouse proteasomal ATPases Psmc3 and Psmc4: genomic organization and gene targeting.","date":"2000","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10945464","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8082782","id":"PMC_8082782","title":"Identification of a novel mammalian member of the NSF/CDC48p/Pas1p/TBP-1 family through heterologous expression in yeast.","date":"1994","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8082782","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37256937","id":"PMC_37256937","title":"PSMC3 proteasome subunit variants are associated with neurodevelopmental delay and type I interferon production.","date":"2023","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37256937","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19853614","id":"PMC_19853614","title":"The 19S ATPase S6a (S6'/TBP1) regulates the transcription initiation of class II transactivator.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19853614","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1388730","id":"PMC_1388730","title":"Isolation of a yeast gene encoding a protein homologous to the human Tat-binding protein TBP-1.","date":"1992","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/1388730","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8109176","id":"PMC_8109176","title":"AFG2, an essential gene in yeast, encodes a new member of the Sec18p, Pas1p, Cdc48p, TBP-1 family of putative ATPases.","date":"1993","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8109176","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19325002","id":"PMC_19325002","title":"Tat-binding protein-1 (TBP-1), an ATPase of 19S regulatory particles of the 26S proteasome, enhances androgen receptor function in cooperation with TBP-1-interacting protein/Hop2.","date":"2009","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19325002","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17334400","id":"PMC_17334400","title":"TBP-1 protects the human oncosuppressor p14ARF from proteasomal degradation.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17334400","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9345291","id":"PMC_9345291","title":"Molecular cloning and characterization of a novel TBP-1 interacting protein (TBPIP):enhancement of TBP-1 action on Tat by TBPIP.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9345291","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20738257","id":"PMC_20738257","title":"Transcriptional activation requires protection of the TATA-binding protein Tbp1 by the ubiquitin-specific protease Ubp3.","date":"2010","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/20738257","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7766893","id":"PMC_7766893","title":"Structure and expression of LeMA-1, a tomato protein belonging to the SEC18-PAS1-CDC48-TBP-1 protein family of putative Mg(2+)-dependent ATPases.","date":"1995","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7766893","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35695579","id":"PMC_35695579","title":"Hepatitis B Virus X Protein Is Stabilized by the Deubiquitinating Enzyme VCPIP1 in a Ubiquitin-Independent Manner by Recruiting the 26S Proteasome Subunit PSMC3.","date":"2022","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/35695579","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23617410","id":"PMC_23617410","title":"The proteasome cap RPT5/Rpt5p subunit prevents aggregation of unfolded ricin A chain.","date":"2013","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/23617410","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9048938","id":"PMC_9048938","title":"Localization of genes encoding two human one-domain members of the AAA family: PSMC5 (the thyroid hormone receptor-interacting protein, TRIP1) and PSMC3 (the Tat-binding protein, TBP1).","date":"1997","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9048938","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32196577","id":"PMC_32196577","title":"Circ PSMC3 inhibits prostate cancer cell proliferation by downregulating DGCR8.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32196577","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9714759","id":"PMC_9714759","title":"Cloning and heterogeneous in vivo expression of Tat binding protein-1 (TBP-1) in the mouse.","date":"1998","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9714759","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39293861","id":"PMC_39293861","title":"Procyanidin B1 Promotes PSMC3-NRF2 Ubiquitination to Induce Ferroptosis in Glioblastoma.","date":"2024","source":"Phytotherapy research : PTR","url":"https://pubmed.ncbi.nlm.nih.gov/39293861","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17680779","id":"PMC_17680779","title":"TFIIB/SUA7(E202G) is an allele-specific suppressor of TBP1(E186D).","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17680779","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21991300","id":"PMC_21991300","title":"A regulatory mechanism involving TBP-1/Tat-Binding Protein 1 and Akt/PKB in the control of cell proliferation.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21991300","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34883412","id":"PMC_34883412","title":"Prioritization of human well-being spectrum related GWAS-SNVs using ENCODE-based web-tools predict interplay between PSMC3, ITIH4, and SERPINC1 genes in modulating well-being.","date":"2021","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/34883412","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38731881","id":"PMC_38731881","title":"Rpt5-Derived Analogs Stimulate Human Proteasome Activity in Cells and Degrade Proteins Forming Toxic Aggregates in Age-Related Diseases.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38731881","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9327593","id":"PMC_9327593","title":"Expression of a gene for a protein similar to HIV-1 Tat binding protein 1 (TBP1) in floral organs of Brassica rapa.","date":"1997","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9327593","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10363644","id":"PMC_10363644","title":"Activator complexes containing the proteasomal regulatory ATPases S10b (SUG2) and S6 (TBP1) in different tissues and organisms.","date":"1999","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/10363644","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37386751","id":"PMC_37386751","title":"A Moroccan Pyrenophora teres f. teres Population Defeats Rpt5, the Broadly Effective Resistance on Barley Chromosome 6H.","date":"2024","source":"Phytopathology","url":"https://pubmed.ncbi.nlm.nih.gov/37386751","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38005983","id":"PMC_38005983","title":"In Vivo Validation of Novel Synthetic tbp1 Peptide-Based Vaccine Candidates against Haemophilus influenzae Strains in BALB/c Mice.","date":"2023","source":"Vaccines","url":"https://pubmed.ncbi.nlm.nih.gov/38005983","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36528617","id":"PMC_36528617","title":"PSMC3 promotes RNAi by maintaining AGO2 stability through USP14.","date":"2022","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/36528617","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9473711","id":"PMC_9473711","title":"Distribution of mRNA encoding Tat-binding protein-1 (TBP-1), a component of 26S proteasome, in the rat brain.","date":"1998","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9473711","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8863736","id":"PMC_8863736","title":"Genomic structure of the maize TATA-box binding protein 1 (TBP-1): conserved exon/intron structure in eukaryotic TBP genes.","date":"1996","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8863736","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24817721","id":"PMC_24817721","title":"Purification, crystallization and preliminary X-ray data collection of the N-terminal domain of the 26S proteasome regulatory subunit p27 and its complex with the ATPase domain of Rpt5 from Mus musculus.","date":"2014","source":"Acta crystallographica. Section F, Structural biology communications","url":"https://pubmed.ncbi.nlm.nih.gov/24817721","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35114005","id":"PMC_35114005","title":"The 19S proteasome subunit Rpt5 reversibly associates with cold-stable microtubules in glial cells at low temperatures.","date":"2022","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/35114005","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9382765","id":"PMC_9382765","title":"Cloning and sequencing of the gene encoding the outer-membrane protein Tbp1 from Actinobacillus pleuropneumoniae. Expression of Tbp1 and Tbp2.","date":"1997","source":"Behring Institute Mitteilungen","url":"https://pubmed.ncbi.nlm.nih.gov/9382765","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41001458","id":"PMC_41001458","title":"Neuroimaging PheWAS and molecular phenotyping implicate PSMC3 in Alzheimer's Disease.","date":"2025","source":"medRxiv : the preprint server for health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41001458","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41732108","id":"PMC_41732108","title":"Neuroimaging PheWAS and molecular phenotyping implicate PSMC3 in Alzheimer's disease.","date":"2026","source":"Alzheimer's & dementia : the journal of the Alzheimer's Association","url":"https://pubmed.ncbi.nlm.nih.gov/41732108","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.18.25336095","title":"Neuroimaging PheWAS and molecular phenotyping implicate <i>PSMC3</i> in Alzheimer’s Disease","date":"2025-09-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.18.25336095","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.19.25336146","title":"Complex Genetics and Regulatory Drivers of Hypermobile Ehlers-Danlos Syndrome: Insights from Genome-Wide Association Study Meta-analysis","date":"2025-09-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.19.25336146","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.10.16.682926","title":"Integrated phenotypic and proteomic screening identifies top-tier Alzheimer’s disease therapeutic targets","date":"2025-10-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.16.682926","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.09.22.677762","title":"T13F2.2 of <i>C. elegans</i> is Critical for Chromatin Organization, Autophagy, and Longevity","date":"2025-09-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.22.677762","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.08.09.607401","title":"Rpt5 encodes a receptor-like protein that provides broad and effective net form net blotch (Pyrenophora teres f. teres) resistance in barley","date":"2024-08-10","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.09.607401","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"8811196","id":"PMC_8811196","title":"Structure and functions of the 20S and 26S proteasomes.","date":"1996","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8811196","citation_count":2108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12167863","id":"PMC_12167863","title":"Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.","date":"2002","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12167863","citation_count":1924,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22658674","id":"PMC_22658674","title":"Insights into RNA biology from an atlas of mammalian mRNA-binding proteins.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22658674","citation_count":1718,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19489727","id":"PMC_19489727","title":"Recognition and processing of ubiquitin-protein conjugates by the proteasome.","date":"2009","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19489727","citation_count":1398,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19615732","id":"PMC_19615732","title":"Defining the human deubiquitinating enzyme interaction landscape.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19615732","citation_count":1282,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12808466","id":"PMC_12808466","title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12808466","citation_count":1236,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12809610","id":"PMC_12809610","title":"DNA deamination mediates innate immunity to retroviral infection.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12809610","citation_count":1150,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14564014","id":"PMC_14564014","title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.","date":"2003","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/14564014","citation_count":1006,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12808465","id":"PMC_12808465","title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12808465","citation_count":912,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23503661","id":"PMC_23503661","title":"Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization.","date":"2013","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23503661","citation_count":870,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14743216","id":"PMC_14743216","title":"A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.","date":"2004","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/14743216","citation_count":841,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14528300","id":"PMC_14528300","title":"The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.","date":"2003","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/14528300","citation_count":798,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18854154","id":"PMC_18854154","title":"Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18854154","citation_count":787,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12859895","id":"PMC_12859895","title":"Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12859895","citation_count":763,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14528301","id":"PMC_14528301","title":"HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.","date":"2003","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/14528301","citation_count":679,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16713569","id":"PMC_16713569","title":"A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16713569","citation_count":610,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14527406","id":"PMC_14527406","title":"HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.","date":"2003","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/14527406","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12750511","id":"PMC_12750511","title":"Hypermutation of HIV-1 DNA in the absence of the Vif protein.","date":"2003","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12750511","citation_count":570,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21801,"output_tokens":4248,"usd":0.064561},"stage2":{"model":"claude-opus-4-6","input_tokens":7708,"output_tokens":3672,"usd":0.19551},"total_usd":0.555246,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":32783,"output_tokens":7319,"usd":0.104067},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9816,"output_tokens":3133,"usd":0.191108}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2020,\n      \"finding\": \"PSMC3 (Rpt5) variants cause proteotoxic stress in patient fibroblasts: a deep intronic homozygous variant introduces a cryptic exon, leading to accumulation of ubiquitinated proteins and permanent activation of the TCF11/Nrf1 transcriptional pathway for proteasome recovery, while impairing compensatory proteasome upregulation upon chemical inhibition. Zebrafish PSMC3 knockout reproduced inner ear and lens developmental defects.\",\n      \"method\": \"Whole-genome sequencing, patient fibroblast proteasome activity assays, ubiquitinated protein accumulation assay, TCF11/Nrf1 pathway reporter, zebrafish knockout phenotyping\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in patient cells plus in vivo zebrafish model, moderate evidence\",\n      \"pmids\": [\"32500975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"De novo missense variants in PSMC3 disrupt substrate translocation by the AAA-ATPase, inducing proteotoxic stress in T cells that activates protein kinase R (PKR) and drives type I interferon signaling; inhibition of PKR blocked the IFN response. PSMC3 variants also caused altered dendrite development in mouse neuronal cultures and impaired reversal learning in Drosophila upon Rpt5 ortholog deletion.\",\n      \"method\": \"Structural modeling, proteomic/transcriptomic analysis of patient T cells, PKR inhibitor rescue, mouse neuronal culture morphology, Drosophila behavioral assay\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (proteomics, transcriptomics, structural modeling, PKR inhibitor rescue, two model organisms) in a single rigorous study\",\n      \"pmids\": [\"37256937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PSMC3 (TBP-1/S6a), a 19S proteasome ATPase subunit, is required for cytokine-inducible transcription of CIITA (master MHC-II regulator): S6a knockdown reduces recruitment of transcription factors to the CIITA interferon-gamma-inducible promoter IV and decreases H3K18 and H4K8 acetylation. S6b binds the CIITA promoter in an S6a-dependent manner.\",\n      \"method\": \"siRNA knockdown, chromatin immunoprecipitation, histone acetylation assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with defined chromatin/transcriptional phenotype, single lab\",\n      \"pmids\": [\"19853614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PSMC3 (TBP-1) directly binds the androgen receptor (AR) and TBPIP in vitro and in LNCaP cells; TBP-1 is transiently recruited to the androgen response element of the PSA gene promoter in a ligand-dependent manner; the ATPase domain and leucine zipper of TBP-1 are required for transcriptional enhancement of AR-mediated transcription.\",\n      \"method\": \"Yeast two-hybrid, in vitro binding, co-immunoprecipitation in LNCaP cells, chromatin immunoprecipitation, domain deletion mutagenesis, reporter assay\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, ChIP, and mutagenesis in single study\",\n      \"pmids\": [\"19325002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PSMC3 (TBP-1) stabilizes the p14ARF tumor suppressor by protecting it from proteasomal degradation: TBP-1 counteracts 20S proteasome-mediated, ubiquitin-independent degradation of ARF in vitro, requiring an intact N-terminal 39 amino acids of ARF.\",\n      \"method\": \"In vitro 20S proteasome degradation assay, protein stability assays, domain deletion analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstituted degradation assay with domain mapping, single lab\",\n      \"pmids\": [\"17334400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PSMC3 (TBP-1) knockdown in human fibroblasts activates Akt/PKB kinase, increases cell proliferation, migration, and apoptosis resistance; TBP-1 is itself a downstream target of Akt, and MDM2 (an Akt target) mediates this regulation, suggesting a negative feedback loop.\",\n      \"method\": \"Stable shRNA knockdown, proliferation/migration/apoptosis assays, Akt phosphorylation western blot, rescue experiments\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with defined cellular and signaling phenotypes, single lab\",\n      \"pmids\": [\"21991300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The C-terminal tail of Rpt5 (PSMC3 yeast ortholog) performs two distinct functions: facilitating interaction with the 20S core particle (CP) and binding to the assembly chaperone Nas2/p27. Loss of CP interaction leads to incorporation of faulty proteasomes recognized and inhibited by Ecm29; deletion of ECM29 rescues rpt5 tail mutant phenotypes, placing Ecm29 as a negative regulator of aberrant proteasomes downstream of Rpt5-CP interaction.\",\n      \"method\": \"C-terminal deletion mutagenesis in S. cerevisiae, proteasome purification, peptidase activity assay, genetic epistasis (ecm29Δ suppression)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay with purified proteasomes, mutagenesis, and genetic epistasis; single rigorous study\",\n      \"pmids\": [\"21878651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Both Psmc3 and Psmc4 are essential for early embryogenesis in mice: targeted gene knockout of either gene causes lethality before implantation with defective blastocyst development, and neither compensates for loss of the other.\",\n      \"method\": \"Gene targeting (knockout mice), blastocyst development phenotyping\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined developmental phenotype, replicated for two paralogs in same study\",\n      \"pmids\": [\"10945464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"During rat spermatid development, PSMC3 (a 19S proteasome component) interacts with Rnf19a (a ubiquitin E3 ligase) and both proteins localize to Golgi-derived proacrosomal vesicles, the acrosomal membrane, acroplaxome, and the head-tail coupling apparatus, implicating the ubiquitin-proteasome system in acrosome biogenesis, spermatid head shaping, and tail development.\",\n      \"method\": \"Co-immunoprecipitation, indirect immunofluorescence, immunogold electron microscopy, subcellular fractionation\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP and localization experiments without direct functional loss-of-function in same study\",\n      \"pmids\": [\"19517565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The RPT5 (PSMC3) AAA-ATPase subunit of the 26S proteasome acts as a chaperone that prevents aggregation of denatured ricin A chain (RTA) and stimulates recovery of RTA catalytic activity in vitro, while casein (another substrate) is degraded; in yeast, Rpt5p ATPase activity is required for maximal RTA cytotoxicity after ER dislocation.\",\n      \"method\": \"In vitro proteasome binding and chaperone assay with purified 26S proteasome and denatured substrates, S. cerevisiae genetic analysis of Rpt5p ATPase mutants\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified proteins plus yeast genetic validation, single lab\",\n      \"pmids\": [\"23617410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PSMC3 interacts with AGO2 via its N-terminal coiled-coil motif in an RNA-independent manner; PSMC3 facilitates the interaction of AGO2 with the deubiquitylase USP14, promoting USP14-mediated deubiquitination and stabilization of AGO2, thereby maintaining effective RNAi. PSMC3 depletion increases AGO2 ubiquitination and degradation by the 26S proteasome.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, domain truncation mapping, cycloheximide chase, ubiquitination assay, RNAi reporter (EGFP) assay, siRNA knockdown/overexpression\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, domain mapping, ubiquitination assay, and functional RNAi readout, single lab\",\n      \"pmids\": [\"36528617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PSMC3 forms a ternary complex with the deubiquitylase VCPIP1 and hepatitis B virus X protein (HBx): VCPIP1 recruits PSMC3 to bind HBx, and purified His-PSMC3 directly rescues HBx from 20S proteasome degradation in vitro via a ubiquitin-independent mechanism, stabilizing HBx.\",\n      \"method\": \"74-DUB yeast two-hybrid screen, co-immunoprecipitation, in vitro 20S proteasome degradation assay with purified proteins, HBx ubiquitination site mutant validation\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstituted degradation assay with purified PSMC3 plus Co-IP, single lab\",\n      \"pmids\": [\"35695579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Under cold stress, Rpt5 (PSMC3) dissociates from the 26S proteasome and reversibly relocates to cold-stable microtubules in glial cells; this association is modulated by the microtubule-associated protein MAP6 and by post-translational acetylation of α-tubulin.\",\n      \"method\": \"Subcellular fractionation, immunofluorescence, 20S proteolytic activity assay, western blotting of polyubiquitinated proteins\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — localization/fractionation without direct functional consequence of Rpt5-microtubule interaction, single lab\",\n      \"pmids\": [\"35114005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PSMC3 mediates ubiquitin-dependent degradation of NRF2 in glioblastoma cells: procyanidin B1 promotes the physical interaction between PSMC3 and NRF2, leading to NRF2 ubiquitination and proteasomal degradation, thereby inducing ferroptosis.\",\n      \"method\": \"Protein-small molecule docking, surface plasmon resonance, immunoprecipitation, mass spectrometry, western blotting, intracranial GBM orthotopic mouse model\",\n      \"journal\": \"Phytotherapy research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — SPR, Co-IP, MS, and in vivo model converging on PSMC3-NRF2 interaction and degradation, single lab\",\n      \"pmids\": [\"39293861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The N-terminal domain of the assembly chaperone p27 (Nas2) forms a complex with the C-terminal ATPase domain of Rpt5 (PSMC3 mouse ortholog); crystals of the p27(1-128)–Rpt5(173-442) complex were obtained, supporting direct physical interaction for proteasome assembly.\",\n      \"method\": \"Protein purification, crystallization, X-ray diffraction (4 Å resolution crystal structure of complex)\",\n      \"journal\": \"Acta crystallographica Section F\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — structural crystallography of the complex, but only preliminary data (4 Å), single report\",\n      \"pmids\": [\"24817721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Rat PSMC3 (rtTBP-1) protein colocalizes with α-tubulin-decorated manchettes of elongating spermatids and is also detected in paraaxonemal mitochondria and outer dense fibers of the developing spermatid tail, establishing its subcellular localization during spermiogenesis.\",\n      \"method\": \"Indirect immunofluorescence, immunogold electron microscopy, in situ hybridization\",\n      \"journal\": \"Molecular reproduction and development\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — localization only, no direct functional loss-of-function\",\n      \"pmids\": [\"9266764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Synthetic peptides based on the C-terminus of Rpt5 (PSMC3) stimulate human 20S proteasome activity in vitro and, when conjugated to a cell-penetrating TAT peptide, enhance proteasome activity in HEK293T cells and promote degradation of aggregation-prone α-synuclein and Tau-441.\",\n      \"method\": \"In vitro fluorogenic proteasome activity assay, cell-permeable substrate assay in HEK293T cells, α-synuclein/Tau degradation assay\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro and cell-based reconstitution of Rpt5 C-terminus activating 20S proteasome, single lab\",\n      \"pmids\": [\"38731881\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PSMC3 (Rpt5) is an AAA-ATPase subunit of the 19S regulatory particle of the 26S proteasome whose C-terminal tail mediates interactions with the 20S core particle and the assembly chaperone Nas2/p27; it unfolds and translocates protein substrates for degradation, acts as a chaperone preventing aggregation of misfolded proteins, stabilizes specific substrates (p14ARF, AGO2, HBx) through ubiquitin-dependent and -independent mechanisms, promotes NRF2 ubiquitin-dependent degradation, regulates transcription of MHC-II and androgen-responsive genes via recruitment to promoters, and is essential for early embryogenesis, inner ear/lens development, and neuronal dendrite morphogenesis, with loss-of-function causing proteotoxic stress that activates PKR-driven type I interferon signaling.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper before extracting discoveries.\n\n**Classification:**\n\nPapers 1-2: EXCLUDE — TBP-1 peptide binding titanium / Neisseria Tbp1 (alias collision, different proteins)\nPaper 3: EXCLUDE — Arabidopsis RPT5a (plant ortholog, fundamentally different context — symbol collision)\nPaper 4: KEEP — PSMC3/Rpt5 variants causing deafness/cataracts\nPaper 5: KEEP — Yeast Rpt5 (ortholog) C-terminal interactions with CP and Nas2\nPaper 6: KEEP — Rat Psmc3 in spermatid development\nPaper 7: KEEP — Rat rtTBP-1 (PSMC3 ortholog) in spermatid manchette\nPaper 8: KEEP — Mouse Psmc3 genomic organization and gene targeting\nPaper 9: EXCLUDE — SKD1/SKD2 are different family members (NSF-like); not PSMC3\nPaper 10: KEEP — PSMC3 variants and neurodevelopmental delay\nPaper 11: KEEP — 19S ATPase S6a (TBP-1/PSMC3) regulates CIITA transcription\nPaper 12: EXCLUDE — Yeast TBPY = TATA-binding protein (alias collision)\nPaper 13: EXCLUDE — AFG2 yeast gene (not PSMC3 ortholog)\nPaper 14: KEEP — TBP-1 (PSMC3) enhances androgen receptor function\nPaper 15: KEEP — TBP-1 (PSMC3) protects p14ARF from proteasomal degradation\nPaper 16: KEEP — TBPIP interacts with TBP-1 (PSMC3), modulates Tat transactivation\nPaper 17: EXCLUDE — Tbp1 in yeast = TATA-binding protein (alias collision)\nPaper 18: EXCLUDE — LeMA-1 from tomato (plant, alias collision)\nPaper 19: KEEP — PSMC3 forms ternary complex with VCPIP1 and HBx, stabilizes HBx\nPaper 20: KEEP — RPT5/Rpt5p chaperone activity preventing RTA aggregation\nPaper 21: KEEP — PSMC3 chromosomal localization (11p12-p13)\nPaper 22: EXCLUDE — CircPSMC3 (alt-locus product, case B)\nPaper 23: KEEP — Mouse TBP-1 (PSMC3) cloning, nuclear localization in testis\nPaper 24: KEEP — Procyanidin B1 promotes PSMC3-NRF2 ubiquitination/ferroptosis\nPaper 25: EXCLUDE — TFIIB suppressor of yeast TBP1(E186D) — yeast TATA-binding protein (alias collision)\nPaper 26: KEEP — TBP-1/PSMC3 regulates cell proliferation via Akt/PKB pathway\nPaper 27: EXCLUDE — GWAS/bioinformatic study, no direct mechanism\nPaper 28: KEEP — Rpt5 C-terminus peptides activate 20S proteasome, degrade α-synuclein/Tau\nPaper 29: EXCLUDE — Brassica rapa TBP-like gene (plant, alias collision)\nPaper 30: KEEP — S6'/TBP-1 (PSMC3) in activator complex stimulating 20S proteasome\nPaper 31: EXCLUDE — Barley Rpt5 resistance gene (plant disease, symbol collision)\nPaper 32: EXCLUDE — Haemophilus influenzae tbp1 vaccine (bacterial, alias collision)\nPaper 33: KEEP — PSMC3 maintains AGO2 stability through USP14\nPaper 34: KEEP — TBP-1 mRNA distribution in rat brain (localization)\nPaper 35: EXCLUDE — Maize TATA-box binding protein gene (plant, alias collision)\nPaper 36: KEEP — Crystal structure of p27 N-terminal domain with Rpt5 ATPase domain\nPaper 37: KEEP — Rpt5 associates with cold-stable microtubules in glial cells\nPaper 38: EXCLUDE — Actinobacillus pleuropneumoniae Tbp1 (bacterial, alias collision)\nPaper 39-41: EXCLUDE — Neuroimaging/expression association studies, no direct mechanism\nPaper 42: EXCLUDE — GWAS preprint, no direct mechanism for PSMC3\nPaper 43: EXCLUDE — Screening study, no direct PSMC3 mechanism\nPaper 44: EXCLUDE — C. elegans tbp-1 = TATA-binding protein (alias collision)\nPaper 45: EXCLUDE — Barley Rpt5 resistance gene (plant, symbol collision)\n\n**Additional curated papers:**\nPaper 1 (PMID 8811196): KEEP — foundational review of 26S proteasome structure/function\nPapers 2-30 in curated list: Mostly EXCLUDE (APOBEC3G/CEM15 papers, interactome databases without PSMC3-specific mechanism). PMID 19489727 KEEP (proteasome review). PMID 19615732 KEEP (DUB landscape — mentions PSMC3 interactions).\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"The 26S proteasome 19S regulatory complex contains multiple ATPase subunits (including PSMC3/Rpt5) that are required for binding and unfolding ubiquitinated protein substrates prior to degradation by the 20S core particle; the ATPases form a ring that drives substrate translocation through the gated channel.\",\n      \"method\": \"Biochemical purification, enzymatic assays, subunit characterization\",\n      \"journal\": \"Annual review of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — foundational biochemical reconstitution and purification work, widely replicated across labs\",\n      \"pmids\": [\"8811196\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Rat testis TBP-1 (rtTBP-1, the PSMC3 ortholog) encodes a 49 kDa protein with a leucine zipper domain and conserved ATPase/helicase motifs. By immunofluorescence and immunogold electron microscopy, rtTBP-1 colocalizes with α-tubulin-decorated manchettes of elongating spermatids and is also detected in paraaxonemal mitochondria and outer dense fibers of the developing spermatid tail.\",\n      \"method\": \"Immunofluorescence, immunogold electron microscopy, chromatofocusing fractionation, in situ hybridization\",\n      \"journal\": \"Molecular reproduction and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization by multiple imaging methods in a single study\",\n      \"pmids\": [\"9266764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"PSMC3 (TBP-1/Rpt5) was chromosomally mapped to human chromosome 11p12-p13, and a processed pseudogene locus was identified on chromosome 9p.\",\n      \"method\": \"Fluorescence in situ hybridization (FISH), radiation hybrid mapping\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct cytogenetic mapping\",\n      \"pmids\": [\"9048938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"TBPIP (TBP-1-interacting protein) was cloned from mouse and shown to interact with mouse TBP-1 (PSMC3 ortholog) in vivo; TBPIP co-localizes with TBP-1 and synergistically enhances TBP-1's inhibitory action on HIV-1 Tat-mediated transactivation in vitro.\",\n      \"method\": \"Yeast two-hybrid, co-localization, in vitro transactivation assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — yeast two-hybrid plus functional assay in single study\",\n      \"pmids\": [\"9345291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Mouse TBP-1 (PSMC3) is primarily localized to the nuclei of spermatogonia and spermatocytes in the testis, as demonstrated by immunohistochemistry; expression is also confirmed in CD4+ lymphocytes by RT-PCR, indicating heterogeneous tissue distribution.\",\n      \"method\": \"Immunohistochemistry, in situ hybridization, RT-PCR\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct localization experiments with multiple methods\",\n      \"pmids\": [\"9714759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PSMC3 (S6'/TBP-1) is a component of an activator complex (modulator) that, together with S10b (SUG2), stimulates 20S proteasome activity in an ATP- and concentration-dependent manner. This activator complex was isolated from bovine red cells and human tissues (brain, placenta, HEK cells) and also activates 26S proteasomes in a cross-species manner.\",\n      \"method\": \"Biochemical purification, 20S proteasome activity assay, cross-species activation experiments\",\n      \"journal\": \"Molecular biology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro functional assay with purified components, replicated across tissues and species\",\n      \"pmids\": [\"10363644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Mouse Psmc3 gene consists of 12 coding exons with structural similarity to Psmc4; Psmc3 maps to mouse chromosome 2. Gene-targeted Psmc3-deficient mice die before implantation with defective blastocyst development, demonstrating that PSMC3 is essential for early embryogenesis and that Psmc3 and Psmc4 have non-compensatory functions in vivo.\",\n      \"method\": \"Gene targeting (knockout mice), genomic sequencing, embryo analysis\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout with defined lethal phenotype, rigorous genetic study\",\n      \"pmids\": [\"10945464\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"TBP-1 (PSMC3) stabilizes the p14ARF tumor suppressor by protecting it from 20S proteasome-mediated degradation. This stabilization requires an intact N-terminal 39 amino acids of ARF and occurs independently of N-terminal ubiquitination. In vitro, p14ARF can be degraded by the 20S proteasome without ubiquitination, and this degradation is counteracted by TBP-1.\",\n      \"method\": \"In vitro 20S proteasome degradation assay, co-immunoprecipitation, western blotting, deletion mutagenesis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution assay combined with mutagenesis and co-IP in single study\",\n      \"pmids\": [\"17334400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"During rat spermatid development, PSMC3 (a component of the 19S regulatory cap of the 26S proteasome) and the ubiquitin E3 ligase Rnf19a are initially found in Golgi-derived proacrosomal vesicles, then localize along the cytosolic side of acrosomal membranes and the acroplaxome, and subsequently accumulate at the acroplaxome marginal ring-manchette perinuclear ring region and the developing head-tail coupling apparatus, implicating the ubiquitin-proteasome system in acrosome biogenesis and spermatid head shaping.\",\n      \"method\": \"Immunofluorescence, immunogold electron microscopy, cDNA cloning, co-localization studies\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct localization by multiple imaging methods with functional context\",\n      \"pmids\": [\"19517565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The 19S ATPase S6a (TBP-1/PSMC3) is required for cytokine-inducible CIITA transcription: knockdown of S6a reduces recruitment of transcription factors to the CIITA interferon-γ-inducible promoter IV (pIV), decreases histone H3K18 and H4K8 acetylation at that promoter, and impairs CIITA mRNA expression. S6b (another 19S ATPase) binds CIITApIV in an S6a-dependent manner, implicating the 19S ATPase hexamer in transcriptional initiation machinery assembly.\",\n      \"method\": \"siRNA knockdown, chromatin immunoprecipitation (ChIP), RT-PCR, reporter assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and functional knockdown with multiple readouts in single study\",\n      \"pmids\": [\"19853614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TBP-1 (PSMC3) directly binds TBPIP through its amino-terminal leucine zipper domain. AR (androgen receptor) is physically associated with TBP-1 and TBPIP both in vitro and in LNCaP cells. TBP-1 augments AR-mediated transcription additively with TBPIP, and the ATPase domain as well as the leucine zipper domain of TBP-1 are required for transcriptional enhancement. TBP-1 is transiently recruited to the proximal androgen response element of the PSA gene promoter in a ligand-dependent manner.\",\n      \"method\": \"Yeast two-hybrid, GST pulldown, co-immunoprecipitation, chromatin immunoprecipitation (ChIP), reporter assay, mutagenesis\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including in vitro binding, co-IP, ChIP, and domain mutagenesis in single study\",\n      \"pmids\": [\"19325002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The C-terminal tail of yeast Rpt5 (PSMC3 ortholog) provides two distinct functions: (1) facilitating the interaction with the proteasome core particle (CP), and (2) enabling binding to the assembly chaperone Nas2/p27. Deletion of the last C-terminal amino acid disrupts CP interaction but not Nas2 binding; deletion of the last three amino acids disrupts both. Proteasomes from rpt5-Δ3 strains are strongly enriched in Ecm29, which inhibits proteasome activity (reduced suc-LLVY-AMC hydrolysis). Deletion of ECM29 rescues the phenotypes of rpt5-Δ3 and nas2Δ in an hsm3Δ background, demonstrating that Ecm29 acts as a negative regulator of faulty proteasomes.\",\n      \"method\": \"Site-directed mutagenesis, proteasome purification, enzymatic activity assay, genetic epistasis, yeast genetics\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis combined with biochemical purification, enzymatic assay, and genetic epistasis in single study\",\n      \"pmids\": [\"21878651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Stable knockdown of TBP-1 (PSMC3) in human immortalized fibroblasts increases cell proliferation, migration, and resistance to serum deprivation-induced apoptosis. TBP-1 silencing activates Akt/PKB kinase, and TBP-1 is itself a downstream target of Akt/PKB. MDM2, a known Akt target, plays a major role in this regulation, suggesting a negative feedback loop where Akt/PKB modulates TBP-1 levels in proliferating cells.\",\n      \"method\": \"Stable shRNA knockdown, proliferation assays, migration assays, apoptosis assay, western blotting, kinase pathway analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — loss-of-function with multiple phenotypic readouts and pathway placement, single lab\",\n      \"pmids\": [\"21991300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The 26S proteasome AAA-ATPase subunit RPT5 (PSMC3 ortholog) acts as a molecular chaperone that prevents aggregation of denatured ricin A chain (RTA) and stimulates recovery of RTA catalytic activity in vitro. Denatured RTA and casein compete for the same binding site on the regulatory particle of the 26S proteasome, but their fates differ: casein is degraded while RTA is not. In vivo, ATPase activity of yeast Rpt5p is required for maximal RTA toxicity after ER dislocation, implicating RPT5 in substrate triage between folding and degradation pathways.\",\n      \"method\": \"In vitro aggregation assay, proteasome binding competition, catalytic activity measurement, yeast genetic analysis\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution of chaperone activity plus in vivo genetic validation\",\n      \"pmids\": [\"23617410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The N-terminal domain of the assembly chaperone p27 (residues 1-128, mouse) was crystallized alone (1.7 Å resolution, space group P212121) and in complex with the C-terminal ATPase domain of Rpt5/PSMC3 (residues 173-442; 4 Å resolution, space group P222), revealing that the p27 N-terminus directly contacts the Rpt5 ATPase domain and providing structural evidence for their interaction in proteasome assembly.\",\n      \"method\": \"X-ray crystallography, protein purification, co-crystallization\",\n      \"journal\": \"Acta crystallographica. Section F, Structural biology communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure obtained but at low resolution for complex (4 Å); preliminary structural data\",\n      \"pmids\": [\"24817721\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"A deep intronic homozygous variant in PSMC3 leads to transcription of a cryptic exon and impaired protein homeostasis in patient fibroblasts, characterized by accumulation of ubiquitinated proteins (proteotoxic stress). The TCF11/Nrf1 transcriptional pathway for proteasome recovery is constitutively activated in patient cells, but upon chemical proteasome inhibition, this compensatory pathway is impaired. Zebrafish knockout of PSMC3 reproduces the human phenotype with inner ear development anomalies and cataracts, demonstrating a critical role for PSMC3/Rpt5 in inner ear, lens, and CNS development.\",\n      \"method\": \"Whole-genome sequencing, patient fibroblast studies, ubiquitination assays, proteasome activity assays, zebrafish knockout modeling, transcriptional pathway analysis\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (biochemical, cell biology, in vivo modeling) with defined molecular and phenotypic readouts\",\n      \"pmids\": [\"32500975\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PSMC3 is a novel binding partner of AGO2 (Argonaute 2), interacting via the N-terminal coiled-coil motif of PSMC3 in an RNA-independent manner. PSMC3 depletion decreases AGO2 protein amount by promoting its ubiquitination and subsequent 26S proteasome-mediated degradation, whereas PSMC3 overexpression stabilizes AGO2 post-translationally. Mechanistically, PSMC3 facilitates the interaction of AGO2 with the deubiquitylase USP14, promoting USP14-mediated deubiquitination of AGO2, thereby stabilizing AGO2 and maintaining effective RNAi activity.\",\n      \"method\": \"Yeast two-hybrid screen, co-immunoprecipitation, immunofluorescence, truncation mutagenesis, cycloheximide chase, ubiquitination assay, EGFP-RNAi reporter assay, western blotting\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including co-IP, mutagenesis, ubiquitination assay, and functional RNAi readout in single study\",\n      \"pmids\": [\"36528617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"VCPIP1 (a deubiquitinating enzyme) recruits PSMC3 to form a ternary complex with the hepatitis B virus X protein (HBx), stabilizing HBx through a ubiquitin-independent pathway. In vitro, purified His-tagged PSMC3 rescues HBx from 20S proteasome-mediated degradation. VCPIP1 synergizes this stabilization in vivo. The ternary VCPIP1-HBx-PSMC3 complex enhances HBx transcriptional transactivation (NF-κB, AP-1, SP-1) and affects cccDNA transcription.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, in vitro degradation assay with purified proteins, reporter assay, western blotting\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution with purified PSMC3 protein combined with co-IP and functional assays\",\n      \"pmids\": [\"35695579\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Rpt5 (PSMC3) in glial cells reversibly associates with cold-stable microtubules upon cold stress, while other 19S and 20S subunits do not show this redistribution. This relocalization coincides with 26S proteasome partial disassembly and reduced 20S proteolytic activity. Both MAP6 expression and post-translational acetylation of α-tubulin modulate the Rpt5-microtubule association.\",\n      \"method\": \"Immunofluorescence, subcellular fractionation, 20S proteasome activity assay, western blotting, glial cell culture cold stress experiments\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct localization with functional consequence (proteasome disassembly), single lab\",\n      \"pmids\": [\"35114005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Fifteen de novo missense variants in PSMC3 cause an autosomal dominant neurodevelopmental delay syndrome. Expression of PSMC3 variants in mouse neuronal cultures leads to altered dendrite development. Deletion of the PSMC3 Drosophila ortholog Rpt5 impairs reversal learning. Structural modeling and proteomic/transcriptomic analyses of patient T cells indicate that PSMC3 variants disrupt substrate translocation, induce proteotoxic stress, and dysregulate type I interferon (IFN) signaling through activation of the intracellular stress sensor PKR (protein kinase R). Inhibition of PKR blocks the type I IFN response in patient-derived T cells.\",\n      \"method\": \"Patient genetics, structural modeling, mouse neuronal culture with morphological readout, Drosophila behavioral assay, proteomics, transcriptomics, PKR inhibitor treatment\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods across human cells, mouse neurons, and Drosophila model with defined pathway placement (PKR-IFN axis)\",\n      \"pmids\": [\"37256937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Procyanidin B1 mediates interaction between PSMC3 and NRF2 to promote ubiquitin-dependent proteasomal degradation of NRF2 in glioblastoma cells, inducing ferroptosis. PSMC3-NRF2 interaction was demonstrated by immunoprecipitation and mass spectrometry; the mechanism involves enhanced H₂O₂ accumulation through NRF2 downregulation. Procyanidin B1 binding to NRF2 was confirmed by surface plasmon resonance and protein-small molecule docking.\",\n      \"method\": \"Protein-small molecule docking, surface plasmon resonance, z-stack laser confocal imaging, immunoprecipitation, mass spectrometry, western blotting, in vivo orthotopic GBM model\",\n      \"journal\": \"Phytotherapy research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP and MS combined with in vivo model, but mechanistic link of PSMC3 to NRF2 ubiquitination needs further validation\",\n      \"pmids\": [\"39293861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Synthetic peptides and peptidomimetics derived from the C-terminus of the Rpt5 (PSMC3) subunit of the 19S regulatory particle efficiently stimulate human 20S proteasome activity in vitro. Cell-penetrating TAT-conjugated versions stimulate proteasome activity in HEK293T cells (measured with cell-permeable substrate TAS3) and enhance degradation of aggregation-prone α-synuclein and Tau-441.\",\n      \"method\": \"Peptide synthesis, in vitro 20S proteasome activity assay, cell-based proteasome activity assay, western blotting for substrate degradation\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro biochemical assay with defined substrate degradation, extended to cell-based validation\",\n      \"pmids\": [\"38731881\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PSMC3 (Rpt5) is an essential AAA-ATPase subunit of the 19S regulatory particle of the 26S proteasome whose C-terminal tail mediates interactions with both the 20S core particle and the assembly chaperone Nas2/p27; it drives substrate unfolding and translocation for ubiquitin-dependent proteolysis, acts as a molecular chaperone to prevent substrate aggregation, stimulates 20S proteasome activity in a defined activator complex, participates in transcriptional regulation (CIITA, androgen receptor, p14ARF stabilization) through its leucine zipper and ATPase domains, stabilizes AGO2 by facilitating USP14-mediated deubiquitination to maintain RNAi, and its dysfunction causes proteotoxic stress with constitutive TCF11/Nrf1 pathway activation and type I IFN signaling through PKR, resulting in neurodevelopmental and sensory syndromes; it is essential for early embryogenesis, spermatid development, and inner ear/lens development.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PSMC3 (Rpt5) is an AAA-ATPase subunit of the 19S regulatory particle of the 26S proteasome that couples ATP hydrolysis to substrate unfolding, translocation, and gating of the 20S core particle, while also performing non-proteolytic functions in transcriptional regulation, substrate stabilization, and chaperone activity. Its C-terminal tail mediates dual interactions with the 20S core particle and the assembly chaperone Nas2/p27, and synthetic peptides derived from this tail stimulate 20S proteasome activity and promote degradation of aggregation-prone proteins such as α-synuclein [PMID:21878651, PMID:24817721, PMID:38731881]. Beyond proteolysis, PSMC3 is recruited to gene promoters to regulate transcription of MHC-II genes and androgen-responsive genes, stabilizes p14ARF and HBx through ubiquitin-independent protection from 20S degradation, and facilitates USP14-mediated deubiquitination of AGO2 to maintain RNAi [PMID:19853614, PMID:19325002, PMID:17334400, PMID:35695579, PMID:36528617]. Loss-of-function variants in PSMC3 cause a neurodevelopmental syndrome with proteotoxic stress that activates PKR-driven type I interferon signaling, impairs dendrite morphogenesis, and produces inner ear and lens developmental defects [PMID:32500975, PMID:37256937].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Initial characterization placed PSMC3 at specific subcellular structures during spermiogenesis, establishing that this proteasome ATPase subunit localizes beyond the cytosol to manchettes, mitochondria, and outer dense fibers of developing spermatids.\",\n      \"evidence\": \"Immunofluorescence and immunogold EM in rat spermatids\",\n      \"pmids\": [\"9266764\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Localization only; no functional consequence of PSMC3 at these structures was demonstrated\", \"No loss-of-function experiment in spermatids\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Gene knockout revealed that PSMC3 is essential for pre-implantation embryonic development in mice, demonstrating non-redundancy among 19S ATPase subunits.\",\n      \"evidence\": \"Targeted knockout of Psmc3 (and Psmc4) in mice with blastocyst phenotyping\",\n      \"pmids\": [\"10945464\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of embryonic lethality (general proteotoxicity versus specific substrate failure) not resolved\", \"Conditional or tissue-specific knockouts not performed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that PSMC3 stabilizes the p14ARF tumor suppressor by protecting it from ubiquitin-independent 20S proteasomal degradation established a non-canonical, substrate-protective role for a proteasome ATPase subunit.\",\n      \"evidence\": \"In vitro 20S proteasome degradation assay with purified components and domain deletion analysis\",\n      \"pmids\": [\"17334400\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of ARF stabilization by PSMC3 not tested\", \"Structural basis of how PSMC3 shields ARF from 20S degradation unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Two independent studies revealed non-proteolytic transcriptional roles for PSMC3: it is recruited to the CIITA promoter to facilitate MHC-II gene transcription (via histone acetylation and transcription factor recruitment) and to the PSA promoter to enhance androgen receptor-mediated transcription, requiring its ATPase domain.\",\n      \"evidence\": \"siRNA knockdown with ChIP and histone modification assays (CIITA); yeast two-hybrid, Co-IP, ChIP, and reporter assays with domain mutants (AR/PSA)\",\n      \"pmids\": [\"19853614\", \"19325002\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether transcriptional roles are proteasome-independent or require intact 19S complex not fully resolved\", \"Genome-wide scope of PSMC3 transcriptional regulation unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Structure–function analysis of the Rpt5 C-terminal tail in yeast demonstrated it performs dual roles: mediating 20S core particle docking and binding the assembly chaperone Nas2, with the quality-control factor Ecm29 surveilling aberrant proteasomes formed when this interaction is disrupted.\",\n      \"evidence\": \"C-terminal deletion mutagenesis in S. cerevisiae, proteasome purification, peptidase assay, ECM29 genetic epistasis\",\n      \"pmids\": [\"21878651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of the Rpt5 tail–CP interface not resolved in this study\", \"Whether mammalian Ecm29 functions identically not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"PSMC3 knockdown activated Akt/PKB signaling and increased cell proliferation, migration, and apoptosis resistance, identifying a negative feedback loop involving MDM2 and linking proteasome function to growth-factor signaling.\",\n      \"evidence\": \"Stable shRNA knockdown in human fibroblasts with proliferation, migration, and apoptosis assays plus Akt phosphorylation analysis\",\n      \"pmids\": [\"21991300\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Directness of PSMC3–Akt relationship unclear (could be secondary to proteasome impairment)\", \"Mechanism by which MDM2 regulates PSMC3 not elucidated\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Purified 26S proteasome containing Rpt5 was shown to act as a chaperone, preventing aggregation of denatured ricin A chain and restoring its catalytic activity rather than degrading it, with Rpt5 ATPase activity required for maximal toxin refolding in yeast.\",\n      \"evidence\": \"In vitro chaperone assay with purified 26S proteasome and denatured substrates; yeast Rpt5 ATPase mutant analysis\",\n      \"pmids\": [\"23617410\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Chaperone activity attributed to the intact 26S complex, not isolated Rpt5 subunit\", \"Physiological substrates refolded by this mechanism unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Crystallization of the p27(Nas2)–Rpt5 ATPase domain complex provided structural evidence for their direct interaction during proteasome base assembly.\",\n      \"evidence\": \"Protein purification and X-ray crystallography (4 Å resolution) of the p27(1-128)–Rpt5(173-442) complex\",\n      \"pmids\": [\"24817721\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Resolution too low for detailed atomic contacts\", \"Full assembly pathway kinetics not determined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of a pathogenic deep intronic PSMC3 variant in patients linked proteasome dysfunction to a developmental syndrome: patient fibroblasts showed ubiquitinated protein accumulation and constitutive TCF11/Nrf1 activation, and zebrafish knockout recapitulated inner ear and lens defects.\",\n      \"evidence\": \"Whole-genome sequencing, proteasome activity assays in patient fibroblasts, TCF11/Nrf1 pathway analysis, zebrafish PSMC3 knockout phenotyping\",\n      \"pmids\": [\"32500975\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TCF11/Nrf1 activation is compensatory or pathogenic not distinguished\", \"Full spectrum of human clinical phenotype from this variant not captured\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Three studies expanded PSMC3's non-degradative roles: it facilitates USP14-mediated deubiquitination and stabilization of AGO2 to maintain RNAi, forms a ternary complex with VCPIP1 to rescue HBx from 20S degradation, and under cold stress dissociates from proteasomes to associate with cold-stable microtubules in a MAP6/acetylated-tubulin–dependent manner.\",\n      \"evidence\": \"Co-IP, domain mapping, ubiquitination/CHX-chase assays for AGO2 (PMID:36528617); yeast two-hybrid, in vitro 20S degradation with purified PSMC3 for HBx (PMID:35695579); subcellular fractionation and immunofluorescence for microtubule association (PMID:35114005)\",\n      \"pmids\": [\"36528617\", \"35695579\", \"35114005\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Microtubule association functional consequence not established (Low-confidence finding)\", \"Whether AGO2 stabilization is a proteasome-independent function of PSMC3 monomers or requires 19S context unclear\", \"Structural basis of PSMC3-mediated protection from 20S degradation not resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"De novo missense PSMC3 variants were shown to disrupt substrate translocation and trigger a proteotoxic stress response that activates PKR-driven type I interferon signaling, establishing a mechanistic link between proteasome dysfunction and innate immune activation; the variants also impaired dendrite morphogenesis and Drosophila learning.\",\n      \"evidence\": \"Structural modeling, proteomics/transcriptomics in patient T cells, PKR inhibitor rescue, mouse neuronal morphology, Drosophila behavioral assays\",\n      \"pmids\": [\"37256937\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How proteotoxic stress specifically activates PKR (direct unfolded protein sensor vs. intermediate) not fully delineated\", \"Whether PKR inhibition rescues neurodevelopmental phenotypes in vivo not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"The C-terminal peptide of Rpt5 was shown to be sufficient to stimulate 20S proteasome activity and promote degradation of aggregation-prone α-synuclein and Tau in cells, providing a therapeutic proof-of-concept for proteasome activation; separately, PSMC3 was found to mediate NRF2 ubiquitin-dependent degradation in glioblastoma, linking it to ferroptosis regulation.\",\n      \"evidence\": \"In vitro fluorogenic proteasome assay and cell-based α-synuclein/Tau degradation (PMID:38731881); SPR, Co-IP, MS, and orthotopic GBM mouse model for NRF2 degradation (PMID:39293861)\",\n      \"pmids\": [\"38731881\", \"39293861\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo efficacy and specificity of Rpt5 C-terminal peptides not established\", \"Whether PSMC3–NRF2 interaction is direct or mediated by other proteasome subunits not resolved\", \"Relationship between NRF2 degradation and TCF11/Nrf1 compensatory pathway not explored\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis of PSMC3's substrate-protective (anti-degradation) function versus its canonical degradation role, the molecular pathway linking proteasome dysfunction to PKR activation, and whether PSMC3's transcriptional and chaperone activities operate as free subunit or within intact 19S/26S complexes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of PSMC3 in the substrate-protective mode\", \"PKR activation mechanism downstream of proteotoxic stress uncharacterized\", \"Proteasome-dependent versus -independent functions of PSMC3 not systematically separated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [6, 9, 16]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [4, 10, 11, 13]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6, 9, 16]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [12, 15]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 6, 10, 11, 13, 16]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 7]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [\n      \"26S proteasome\",\n      \"19S regulatory particle\"\n    ],\n    \"partners\": [\n      \"NAS2\",\n      \"AGO2\",\n      \"USP14\",\n      \"VCPIP1\",\n      \"AR\",\n      \"CDKN2A\",\n      \"RNF19A\",\n      \"NRF2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"PSMC3 (Rpt5/TBP-1) is an essential AAA-ATPase subunit of the 19S regulatory particle of the 26S proteasome that drives ATP-dependent unfolding and translocation of ubiquitinated substrates into the 20S core for degradation, with its C-terminal tail mediating both 20S core particle docking and assembly chaperone Nas2/p27 binding [PMID:8811196, PMID:21878651, PMID:24817721]. Beyond canonical proteolysis, PSMC3 functions as a molecular chaperone that prevents substrate aggregation, stabilizes p14ARF against ubiquitin-independent 20S degradation, and maintains AGO2 protein levels by facilitating USP14-mediated deubiquitination to sustain RNAi [PMID:23617410, PMID:17334400, PMID:36528617]. PSMC3 also participates in transcriptional regulation, being recruited to promoters of CIITA and androgen receptor target genes through its leucine zipper and ATPase domains [PMID:19853614, PMID:19325002]. De novo missense variants in PSMC3 cause an autosomal dominant neurodevelopmental syndrome characterized by proteotoxic stress and dysregulated type I interferon signaling via PKR, while biallelic loss-of-function variants produce inner ear and lens developmental anomalies [PMID:37256937, PMID:32500975].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing that PSMC3/Rpt5 is a core ATPase subunit of the 19S regulatory particle resolved the enzymatic basis of substrate recognition and translocation in ubiquitin-dependent proteolysis.\",\n      \"evidence\": \"Biochemical purification and enzymatic characterization of the 26S proteasome subunits\",\n      \"pmids\": [\"8811196\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate specificity determinants of individual ATPase subunits were not resolved\", \"Structural arrangement of the ATPase ring was unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Localization of PSMC3 to spermatid manchettes and identification of its leucine zipper domain suggested non-proteasomal roles in germ cell differentiation, expanding PSMC3 function beyond bulk proteolysis.\",\n      \"evidence\": \"Immunofluorescence and immunogold electron microscopy in rat spermatids; domain analysis\",\n      \"pmids\": [\"9266764\", \"9345291\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of manchette localization was not tested\", \"TBPIP interaction validated only by yeast two-hybrid in single study\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstration that PSMC3 together with SUG2 forms an activator complex stimulating 20S proteasome activity in an ATP-dependent manner established that individual 19S ATPases can function outside the intact 26S holoenzyme.\",\n      \"evidence\": \"Purification from bovine red cells and human tissues with in vitro 20S proteasome activity assay\",\n      \"pmids\": [\"10363644\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological context for a free PSMC3-SUG2 activator complex was not defined\", \"Stoichiometry and regulation of the activator complex were not characterized\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Psmc3 knockout in mice demonstrated pre-implantation lethality with defective blastocyst development, proving that PSMC3 is non-redundant with Psmc4 and essential for early embryogenesis.\",\n      \"evidence\": \"Gene-targeted knockout mice with embryo analysis\",\n      \"pmids\": [\"10945464\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether lethality arises from global proteasome failure versus a specific PSMC3 function was unresolved\", \"Cell-type-specific requirements were not addressed\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showing that PSMC3 protects p14ARF from ubiquitin-independent 20S proteasome degradation revealed a substrate-stabilization function distinct from its role in 26S-dependent proteolysis.\",\n      \"evidence\": \"In vitro 20S proteasome degradation assay with purified components, co-IP, and deletion mutagenesis\",\n      \"pmids\": [\"17334400\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether p14ARF stabilization occurs through direct binding or steric exclusion from the 20S gate was not resolved\", \"In vivo relevance for tumor suppression was not demonstrated\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Two contemporaneous studies established transcription-regulatory roles for PSMC3: it is required for CIITA promoter activation through histone acetylation and transcription factor recruitment, and it enhances androgen receptor transactivation via its leucine zipper and ATPase domains.\",\n      \"evidence\": \"siRNA knockdown with ChIP and RT-PCR for CIITA; GST pulldown, co-IP, ChIP, and reporter assays with domain mutagenesis for AR\",\n      \"pmids\": [\"19853614\", \"19325002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether transcriptional roles require assembled 19S particles or free PSMC3 was not distinguished\", \"Genome-wide scope of PSMC3 transcriptional targets was unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Dissection of the Rpt5 C-terminal tail revealed separable functions for 20S core particle docking and Nas2 chaperone binding, establishing how assembly intermediates are guided to the mature holoenzyme.\",\n      \"evidence\": \"C-terminal truncation mutagenesis in yeast combined with proteasome purification, enzymatic assays, and genetic epistasis with ECM29\",\n      \"pmids\": [\"21878651\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the C-tail–CP interface at atomic resolution was not obtained\", \"How Ecm29 senses faulty proteasomes mechanistically was unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Reconstitution of chaperone activity demonstrated that PSMC3/Rpt5 prevents substrate aggregation and promotes refolding, establishing a triage function between folding and degradation at the proteasome.\",\n      \"evidence\": \"In vitro aggregation assay with denatured ricin A chain, competition binding, and yeast ATPase-mutant genetic validation\",\n      \"pmids\": [\"23617410\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Range of endogenous substrates subject to PSMC3-mediated triage was uncharacterized\", \"Structural basis of chaperone versus degradation commitment was unknown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of a pathogenic deep intronic PSMC3 variant causing proteotoxic stress, constitutive TCF11/Nrf1 activation, and inner ear/lens developmental anomalies in humans and zebrafish linked PSMC3 dysfunction to a human sensory-developmental syndrome.\",\n      \"evidence\": \"Whole-genome sequencing of patients, fibroblast proteostasis assays, and zebrafish PSMC3 knockout phenotyping\",\n      \"pmids\": [\"32500975\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TCF11/Nrf1 pathway exhaustion is the proximal cause of tissue-specific defects was not tested\", \"Genotype-phenotype correlation across different variant types was limited\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Discovery that PSMC3 stabilizes AGO2 by facilitating USP14-mediated deubiquitination revealed a proteasome-independent post-translational mechanism through which PSMC3 sustains RNA interference.\",\n      \"evidence\": \"Yeast two-hybrid, co-IP, truncation mutagenesis, cycloheximide chase, ubiquitination assay, and EGFP-RNAi reporter\",\n      \"pmids\": [\"36528617\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PSMC3-AGO2 interaction occurs as free protein or within 19S context was not resolved\", \"Impact on specific miRNA pathways or global small RNA populations was not assessed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Characterization of 15 de novo PSMC3 missense variants established an autosomal dominant neurodevelopmental syndrome and revealed that proteotoxic stress activates PKR-driven type I interferon signaling, identifying a druggable inflammatory axis downstream of proteasome dysfunction.\",\n      \"evidence\": \"Patient genetics, mouse neuronal morphology, Drosophila behavioral assay, proteomics/transcriptomics, PKR inhibitor treatment in patient T cells\",\n      \"pmids\": [\"37256937\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PKR activation is specific to PSMC3 variants or generalizable to other proteasome subunit mutations was untested\", \"Long-term efficacy of PKR inhibition in vivo was not assessed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: how PSMC3 partitions between proteasomal, transcriptional, and chaperone roles in different cell types; the structural basis for substrate triage at the intact 26S holoenzyme; and whether therapeutic activation of the 20S proteasome via Rpt5-derived peptides can ameliorate neurodegenerative proteinopathies in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No in vivo pharmacological validation of Rpt5 C-terminal peptides in neurodegeneration models\", \"Cell-type-specific partitioning of PSMC3 functions is unexplored\", \"High-resolution cryo-EM of PSMC3 in chaperone versus degradation states is lacking\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 5, 11, 13]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 7, 16, 17]},\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [9, 10]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 16, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 9, 10]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 5, 16]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [1, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 5, 7, 11, 13, 16, 17, 21]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [9, 10]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [19]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [6, 15]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [15, 19]}\n    ],\n    \"complexes\": [\n      \"26S proteasome 19S regulatory particle\",\n      \"PSMC3-SUG2 proteasome activator complex\"\n    ],\n    \"partners\": [\n      \"PSMC4\",\n      \"PSMD5\",\n      \"AGO2\",\n      \"USP14\",\n      \"VCPIP1\",\n      \"AR\",\n      \"TBPIP\",\n      \"NAS2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}